Company: BSX
Filing Date: 2025-08-01
Form Type: 10-Q
Source: 0000885725-25-000041
Chunk: 39

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-08-01
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
632,871 1,734,329,744 Common stockBeginning$17 $17 $17 $17 Impact of stock-based compensation plans0 0 0 0 Ending$17 $17 $17 $17 Treasury stockBeginning$(2,251)$(2,251)$(2,251)$(2,251)Repurchase of common stock— — — — Ending$(2,251)$(2,251)$(2,251)$(2,251)Additional paid-in capitalBeginning$21,127 $20,713 $21,056 $20,647 Impact of stock-based compensation plans103 90 174 156 Ending$21,230 $20,803 $21,230 $20,803 Retained earningsBeginning$3,347 $1,314 $2,673 $819 Net income (loss)795 322 1,467 815 Net (income) loss attributable to noncontrolling interests2 2 4 4 Ending$4,144 $1,639 $4,144 $1,639 Accumulated other comprehensive income (loss), net of tax Beginning$(28)$132 $275 $49 Changes in other comprehensive income (loss)(694)31 (996)114 Ending$(722)$164 $(722)$164 Total stockholders' equity$22,418 $20,371 $22,418 $20,371 Noncontrolling interestsBeginning$233 $242 $233 $248 Net income (loss) attributable to noncontrolling interests(2)(2)(4)(4)Changes in other comprehensive income (loss)3 (1)6 (6)Ending$235 $238 $235 $238 Total equity$22,653 $20,609 $22,653 $20,609 

Refer to notes to the unaudited consolidated financial statements. Amounts may not add due to rounding.

6

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

Six Months Ended June 30,(in millions)20252024Net income (loss)$1,467 $815 Adjustments to reconcile net income (loss) to cash provided by (used for)